Print ISSN:-2394-6369

Online ISSN:-2394-6377


Current Issue

Year 2020

Volume: 7 , Issue: 2

Article Access statistics

Viewed: 506

Emailed: 0

PDF Downloaded: 217

International Journal of Clinical Biochemistry and Research

Sialic acid: an early sensitive marker improves detection of nephropathy in type-2 diabetes mellitus patients

Full Text PDF Share on Facebook Share on Twitter

Research Article

Author Details : B Sheshu Kumar, Siraj Ahmed Khan, K S.S Sai Baba, P V. Satyanarayana, Iyyapu Krishna Mohan*

Volume : 6, Issue : 2, Year : 2019

Article Page : 152-156

Suggest article by email


Introduction: Diabetic nephropathy has become the single most important cause of end stage renal disease worldwide. Detection of early stages of diabetic nephropathy with sensitive tests may be useful to prevent progression of nephropathy. The present study was undertaken to study the serum sialic acid levels and microalbuminuria and to assess whether there is a relationship between these two with glycemic control and other parameters in diabetic nephropathy patients.
Materials and Methods: A total number of 100 subjects participated in present study including 50 clinically diagnosed cases of type-2 diabetic nephropathy patients. Fasting and post-prandial blood sugar, urea, creatinine, serum sialic acid and urinary microalbumin levels were estimated.
Results: The mean fasting blood sugar values in cases (181.40±45.82) as compared to controls (89.62±12.53) is statistically significant (p<0 xss=removed xss=removed xss=removed xss=removed> Conclusion: Estimation of serum sialic acid prior to microalbumin in diabetic patients is helpful in assessing the glycemic control and identify the risk of nephropathy which is the main cause for mortality and morbidity among type-2 diabetes mellitus patients.

Keywords: Serum sialic acid, Microalbumin, HbA1c, Nephropathy, Type-2 diabetes mellitus.

Doi : 10.18231/j.ijcbr.2019.036

How to cite : Kumar B S, Khan S A, Baba K S S, Satyanarayana P V, Mohan I K, Sialic acid: an early sensitive marker improves detection of nephropathy in type-2 diabetes mellitus patients. Int J Clin Biochem Res 2019;6(2):152-156

Copyright © 2019 by author(s) and Int J Clin Biochem Res. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC-BY-NC 4.0) (